Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7502)
All Articles published online
|
Publishing Process of This Article
|
Jun 8, 2015 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Antoury C, Lopez R, Zein N, Stoller JK, Alkhouri N. Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease. World J Hepatol 2015; 7(10): 1427-1432 [PMID: 26052388 DOI: 10.4254/wjh.v7.i10.1427] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i10/1427.htm |
| Number | Citing Articles |
| 1 |
Joshua P Kronenfeld, Neha Goel. An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; : 1209 doi: 10.2147/JHC.S284430
|
| 2 |
Olivier Guillaud, Jérôme Dumortier, Eduardo Couchonnal-Bedoya, Mathias Ruiz. Wilson Disease and Alpha1-Antitrypsin Deficiency: A Review of Non-Invasive Diagnostic Tests. Diagnostics 2023; 13(2): 256 doi: 10.3390/diagnostics13020256
|
| 3 |
Yanping Zhao, Lei Ye, Yaping Yu. MicroRNA-126-5p suppresses cell proliferation, invasion and migration by targeting EGFR in liver cancer. Clinics and Research in Hepatology and Gastroenterology 2020; 44(6): 865 doi: 10.1016/j.clinre.2020.03.025
|
| 4 |
El-Gaily A. El-Rayah, Patrick J. Twomey, Eleanor M. Wallace, Peter A. McCormick. Both α-1-antitrypsin Z phenotypes and low caeruloplasmin levels are over-represented in alcohol and nonalcoholic fatty liver disease cirrhotic patients undergoing liver transplant in Ireland. European Journal of Gastroenterology & Hepatology 2018; 30(4): 364 doi: 10.1097/MEG.0000000000001056
|
| 5 |
Reto Eggenschwiler, Mohsen Moslem, Mariane Serra Fráguas, Melanie Galla, Oliver Papp, Maximilian Naujock, Ines Fonfara, Ingrid Gensch, Annabell Wähner, Abbas Beh-Pajooh, Claudio Mussolino, Marcel Tauscher, Doris Steinemann, Florian Wegner, Susanne Petri, Axel Schambach, Emmanuelle Charpentier, Toni Cathomen, Tobias Cantz. Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase. Scientific Reports 2016; 6(1) doi: 10.1038/srep38198
|
| 6 |
Lincoln J Pac, Gregory Cheeney, Maria Westerhoff, Eric Q Konnick, Dina N Greene, Christina M Lockwood. Real-Time PCR to Detect α-1 Antitrypsin S and Z Alleles in Formalin-Fixed Paraffin-Embedded Tissue. The Journal of Applied Laboratory Medicine 2018; 3(1): 18 doi: 10.1373/jalm.2017.025858
|
| 7 |
Virginia C. Clark. Liver Transplantation in Alpha-1 Antitrypsin Deficiency. Clinics in Liver Disease 2017; 21(2): 355 doi: 10.1016/j.cld.2016.12.008
|
| 8 |
Olivier Guillaud, Jérôme Dumortier, Julie Traclet, Lioara Restier, Philippe Joly, Colette Chapuis-Cellier, Alain Lachaux, Jean François Mornex. Assessment of liver fibrosis by transient elastography (Fibroscan®) in patients with A1AT deficiency. Clinics and Research in Hepatology and Gastroenterology 2019; 43(1): 77 doi: 10.1016/j.clinre.2018.08.016
|
| 9 |
Alberto Quaglia, Eve A. Roberts, Michael Torbenson. Macsween's Pathology of the Liver. 2018; : 111 doi: 10.1016/B978-0-7020-6697-9.00003-0
|
| 10 |
Pavel Strnad, Carolin V. Schneider, Virginia Clark. α1-Antitrypsin Deficiency. 2019; doi: 10.1183/2312508X.10033018
|
| 11 |
Nazli Khodayari, Regina Oshins, Alek M. Aranyos, Sergio Duarte, Sayedamin Mostofizadeh, Yuanqing Lu, Mark Brantly. Characterization of hepatic inflammatory changes in a C57BL/6J mouse model of alpha1-antitrypsin deficiency. American Journal of Physiology-Gastrointestinal and Liver Physiology 2022; 323(6): G594 doi: 10.1152/ajpgi.00207.2022
|
| 12 |
Pasquale Piccolo, Sergio Attanasio, Nicola Brunetti-Pierri. α1-Antitrypsin Deficiency. 2019; doi: 10.1183/2312508X.10032818
|
| 13 |
Umur Hatipoğlu, James K. Stoller. α1-Antitrypsin Deficiency. Clinics in Chest Medicine 2016; 37(3): 487 doi: 10.1016/j.ccm.2016.04.011
|
| 14 |
Zuzana Rabekova, Sona Frankova, Milan Jirsa, Magdalena Neroldova, Mariia Lunova, Ondrej Fabian, Martin Kveton, David Varys, Klara Chmelova, Vera Adamkova, Jaroslav A. Hubacek, Julius Spicak, Dusan Merta, Jan Sperl. Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis: SERPINA1 MZ or MS Genotype Carriage Decreases the Risk. International Journal of Molecular Sciences 2021; 22(19): 10560 doi: 10.3390/ijms221910560
|
| 15 |
Mahmoud Aryan, Thomas Ruli, Mohamed Shoreibah. HCC in patients without cirrhosis: A review. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000224
|
| 16 |
Gregory Cheeney, Lincoln J. Pac, Purva Gopal, Charles S. Landis, Eric Q. Konnick, Paul E. Swanson, Dina N. Greene, Christina M. Lockwood, Maria Westerhoff. Increased Frequency of Heterozygous Alpha‐1‐Antitrypsin Deficiency in Liver Explants From Nonalcoholic Steatohepatitis Patients. Liver Transplantation 2020; 26(1): 17 doi: 10.1002/lt.25652
|
| 17 |
Jorge A. Marrero. Surveillance for Hepatocellular Carcinoma. Clinics in Liver Disease 2020; 24(4): 611 doi: 10.1016/j.cld.2020.07.013
|
| 18 |
|
| 19 |
Alberto Quaglia, Eve A. Roberts, Michael Torbenson. MacSween's Pathology of the Liver. 2024; : 122 doi: 10.1016/B978-0-7020-8228-3.00003-X
|
| 20 |
Jose Melendez-Rosado, Ali Alsaad, Fernando F. Stancampiano, William C. Palmer. Abnormal Liver Enzymes. Gastroenterology Nursing 2018; 41(6): 497 doi: 10.1097/SGA.0000000000000346
|
| 21 |
Patrick S Harris, Ross M Hansen, Meagan E Gray, Omar I Massoud, Brendan M McGuire, Mohamed G Shoreibah. Hepatocellular carcinoma surveillance: An evidence-based approach. World Journal of Gastroenterology 2019; 25(13): 1550-1559 doi: 10.3748/wjg.v25.i13.1550
|
| 22 |
Romil Saxena, Pierre Russo. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 133 doi: 10.1016/B978-0-323-42873-6.00009-3
|
| 23 |
Malin Fromme, Pavel Strnad. Liver cancer in severe alpha-1 antitrypsin deficiency: who is at risk?. European Respiratory Journal 2022; 60(5): 2200718 doi: 10.1183/13993003.00718-2022
|
| 24 |
Mehdi Afsharinasab, Amir Hossein Akbari, Vahid Mirzaei, Mehdi Mahmoodi, Mohammad Reza Hajizadeh, Jamal Amri, Alireza Khoshdel. The investigation of the frequency of the alpha-1-antitrypsin phenotype in patients with liver cirrhosis. Hormone Molecular Biology and Clinical Investigation 2022; 43(4): 397 doi: 10.1515/hmbci-2022-0001
|
| 25 |
|
| 26 |
Jorge A. Marrero, Laura M. Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael M. Abecassis, Lewis R. Roberts, Julie K. Heimbach. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2018; 68(2): 723 doi: 10.1002/hep.29913
|
| 27 |
Stefan J. Marciniak, Adriana Ordóñez, Jennifer A. Dickens, Joseph E. Chambers, Vruti Patel, Caia S. Dominicus, Elke Malzer. New Concepts in Alpha-1 Antitrypsin Deficiency Disease Mechanisms. Annals of the American Thoracic Society 2016; 13(Supplement_4): S289 doi: 10.1513/AnnalsATS.201506-358KV
|
| 28 |
Rajeev Khanna, Sanjeev Kumar Verma. Pediatric hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(35): 3980-3999 doi: 10.3748/wjg.v24.i35.3980
|
| 29 |
Rahul Kumar Vempati, Rama Rao Malla. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 63 doi: 10.1016/B978-0-323-99283-1.00012-4
|
| 30 |
Fouad Jaber, George Cholankeril, Hashem B El-Serag. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies. Journal of the Canadian Association of Gastroenterology 2024; 7(5): 331 doi: 10.1093/jcag/gwae025
|
| 31 |
Praveena Narayanan, Pramod K. Mistry. Update on Alpha‐1 Antitrypsin Deficiency in Liver Disease. Clinical Liver Disease 2020; 15(6): 228 doi: 10.1002/cld.896
|
| 32 |
Helena Moreira-Silva, João Amorim, Ermelinda Santos-Silva. Incidental Liver Lesions in children: A practical and evidence-based approach. Clinics and Research in Hepatology and Gastroenterology 2022; 46(5): 101904 doi: 10.1016/j.clinre.2022.101904
|
| 33 |
Nedim Hadžić. Liver Disease in Adolescence. In Clinical Practice 2022; : 99 doi: 10.1007/978-3-030-98808-1_6
|
| 34 |
Jagadeesh Menon, Mukul Vij, Deepti Sachan, Ashwin Rammohan, Naresh Shanmugam, Ilankumaran Kaliamoorthy, Mohamed Rela. Pediatric metabolic liver diseases: Evolving role of liver transplantation. World Journal of Transplantation 2021; 11(6): 161-179 doi: 10.5500/wjt.v11.i6.161
|
| 35 |
Ashraf Omar, Ahmed Kaseb, Tamer Elbaz, Mohamed El-Kassas, Amr El Fouly, Abdel Fatah Hanno, Ahmed El Dorry, Ahmed Hosni, Amr Helmy, Amr S Saad, Ashwaq Alolayan, Basem Eysa, Emad Hamada, Hamdy Azim, Hany Khattab, Hesham Elghazaly, Hesham Tawfik, Hisham Ayoub, Hussein Khaled, Ibtessam Saadeldin, Imam Waked, Eman Barakat, Mahmoud El Meteini, Mohamed Hamed Shaaban, Mohamed EzzElarab, Mohamed Fathy, Mohamed Shaker, Mohamed Sobhi, Mohamed Shaker, Mohamed ElGharib, Mohammed Abdullah, Mohesn Mokhtar, Mostafa Elshazli, Omar Heikal, Osama Hetta, Reda ElWakil, Sameh Abdel Wahab, Samir Eid, Yousri Rostom. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1547 doi: 10.2147/JHC.S404424
|
| 36 |
Saranya Chidambaranathan-Reghupaty, Paul B. Fisher, Devanand Sarkar. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 1 doi: 10.1016/bs.acr.2020.10.001
|